Pacific Biosciences of California, Inc. (PACB) Balance Sheet
As of 2026-06-30 (10-Q), Pacific Biosciences of California, Inc. (PACB) reported total assets of $751.9M, total liabilities of $785.1M and shareholders' equity of -$33.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $61.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PACBPacific Biosciences of California, Inc.Follow PACB — free
—
Price chart with a free account
- Market cap
- 655.9M
- P/E TTM
- —
- Dividend yield
- 0.0%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.06 | 0.05 | 0.03 | 0.04 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.08 | 0.46 | 0.33 | 0.18 | 0.06 | 0.06 | 0.06 | |
| Short-term investments | 0.12 | 0.05 | 0.09 | 0.06 | 0.05 | 0.06 | 0.05 | 0.08 | 0.02 | 0.24 | 0.58 | 0.45 | 0.45 | 0.33 | 0.22 | 0.18 | |
| Receivables | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 | 0.04 | 0.03 | |
| Inventory | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.05 | 0.06 | 0.06 | 0.05 | 0.06 | |
| Current assets | 0.20 | 0.12 | 0.13 | 0.12 | 0.11 | 0.11 | 0.10 | 0.13 | 0.08 | 0.36 | 1.10 | 0.85 | 0.74 | 0.50 | 0.38 | 0.34 | |
| Total assets | 0.22 | 0.13 | 0.14 | 0.12 | 0.13 | 0.14 | 0.14 | 0.17 | 0.15 | 0.41 | 2.01 | 1.77 | 1.75 | 1.26 | 0.78 | 0.75 | |
| Current liabilities | 0.02 | 0.01 | 0.02 | 0.03 | 0.04 | 0.03 | 0.03 | 0.03 | 0.05 | 0.04 | 0.07 | 0.26 | 0.10 | 0.07 | 0.07 | 0.07 | |
| Long-term debt | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | — | 0.90 | 0.90 | — | — | — | — | |
| Short-term debt | 0.00 | 0.00 | — | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — | — | |
| Total liabilities | 0.03 | 0.02 | 0.07 | 0.07 | 0.06 | 0.05 | 0.06 | 0.06 | 0.09 | 0.08 | 1.22 | 1.20 | 1.04 | 0.75 | 0.78 | 0.79 | |
| Shareholders' equity | 0.19 | 0.11 | 0.07 | 0.05 | 0.07 | 0.08 | 0.09 | 0.11 | 0.05 | 0.34 | 0.79 | 0.56 | 0.70 | 0.51 | 0.01 | -0.03 |
USD billions · SEC XBRL
Pacific Biosciences of California, Inc. — questions
- How much cash does Pacific Biosciences of California, Inc. have?
- $61.0M in cash and cash equivalents as of 2026-06-30.
- What are Pacific Biosciences of California, Inc.'s total assets?
- $751.9M as of 2026-06-30.
- What is Pacific Biosciences of California, Inc.'s shareholders' equity?
- -$33.2M as of 2026-06-30.
Every figure on this page comes from Pacific Biosciences of California, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.